Spero Therapeutics
SPRO
#9695
Rank
C$58.73 M
Marketcap
$1.08
Share price
-2.40%
Change (1 day)
-53.99%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2024 (TTM): -C$1.75 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are C$89.86 Million. In 2023 the company made an earning of C$39.85 Million, an increase over its 2022 earnings that were of -C$62.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$1.75 Million-104.37%
2023 C$39.85 M-163.53%
2022 -C$62.73 Million-50.14%
2021 -C$0.13 Billion11.06%
2020 -C$0.12 Billion25.15%
2019 -C$90.52 Million47.68%
2018 -C$61.29 Million5.61%
2017 -C$58.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$42.03 M-50,715.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.29 B-9,994,927.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.90 B-3,498,375.86%๐Ÿ‡จ๐Ÿ‡ฆ Canada